# Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study

> **NCT02083874** · PHASE2 · UNKNOWN · sponsor: **The University of New South Wales** · enrollment: 5 (estimated)

## Conditions studied

- Cannabis Use Disorder

## Interventions

- **DRUG:** CBD

## Key facts

- **NCT ID:** NCT02083874
- **Lead sponsor:** The University of New South Wales
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2014-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083874, "Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02083874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*